Cite
IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
MLA
Otsuki, Takemi, et al. “IL-6 Is a Key Factor in Growth Inhibition of Human Myeloma Cells Induced by Pravastatin, an HMG-CoA Reductase Inhibitor.” International Journal of Oncology, vol. 23, no. 3, Sept. 2003, pp. 763–68. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12888915&authtype=sso&custid=ns315887.
APA
Otsuki, T., Sakaguchi, H., Eto, M., Fujii, T., Hatayama, T., Takata, A., Tsujioka, T., Sugihara, T., & Hyodoh, F. (2003). IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor. International Journal of Oncology, 23(3), 763–768.
Chicago
Otsuki, Takemi, Haruko Sakaguchi, Masaaki Eto, Tomohiro Fujii, Tamayo Hatayama, Akiko Takata, Takayuki Tsujioka, Takashi Sugihara, and Fuminori Hyodoh. 2003. “IL-6 Is a Key Factor in Growth Inhibition of Human Myeloma Cells Induced by Pravastatin, an HMG-CoA Reductase Inhibitor.” International Journal of Oncology 23 (3): 763–68. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12888915&authtype=sso&custid=ns315887.